Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerhard Sauer is active.

Publication


Featured researches published by Gerhard Sauer.


Analytical Biochemistry | 1983

The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors

Peter Krieg; Eberhard Amtmann; Gerhard Sauer

A novel method for the isolation of both macromolecular DNA and RNA from solid tissues based upon the disruption by vibration of deep-frozen material in a mechanical device termed Mikro-dismembrator, is described. This technique reveals a yield of, on the average, 1 to 3 mg of either DNA or RNA per gram of tissue. The quality of the purified nucleic acids permits the detailed analysis of integrated tumor virus DNA sequences and their mRNA transcripts. Furthermore, the efficient isolation of papilloma virions from keratinized wart tissue is facilitated by the application of the Mikro-dismembrator.


Journal of General Virology | 1984

Transcription of Episomal Papillomavirus DNA in Human Condylomata Acuminata and Buschke-Löwenstein Tumours

Hermann Lehn; T.-M. Ernst; Gerhard Sauer

Condylomata acuminata and Buschke-Löwenstein tumours were analysed for the presence of human papillomavirus (HPV) transcripts. HPV DNA and RNA sequences were present in all 13 samples investigated. Ten contained HPV6 and three harboured HPV11. The HPV genomes were found exclusively as extrachromosomal circular molecules. In six biopsy specimens, viral RNA transcripts were not detectable by Northern blot analysis but could be demonstrated in dot blots. From seven HPV6-containing samples it was possible to obtain sufficient amounts of undegraded mRNA. We have found consistently one major species (1.4 kb). Less prominent species of 1.7, 1.85, 2.7 and 3.2 kb, respectively, were also detected. The 3 ends of the HPV6 mRNAs were located between nucleotides 3917 and 4441 in the putative early region and between nucleotides 7232 and 7696 in the putative late region. The arrangement of the 3 termini and the adjacent coding areas within the HPV6 genome show that the RNA species are transcribed from one DNA strand.


Experimental Cell Research | 1985

Reversion of bovine papillomavirus-induced transformation and immortalization by a xanthate compound

Eberhard Amtmann; Karin Müller; Anita C. Knapp; Gerhard Sauer

Bovine papilloma virus-transformed hamster embryo fibroblasts (HEF-BPV) reacted to exposure to tricyclodecan-9-yl-xanthogenate (D609) with immediate reversion to the growth kinetics and the flat morphology of the untransformed parental cells. After six population doublings in the presence of D609, clones which displayed an untransformed morphology in the absence of D609 arose with a high frequency (90%). Such clones had reacquired a limited in vitro lifetime and had lost the ability to induce tumors in athymic nude mice. At the molecular level the revertant clones had lost all extrachromosomal monomeric BPV-1 DNA molecules. Only high molecular weight (HMW) oligomeric BPV-1 DNA that was probably integrated into the cellular genome was still detectable in a methylated transcriptionally inactive state. In contrast to transformed cells, the revertant clones no longer transcribed BPV-1-specific mRNA molecules, but were stimulated by a tumor promoter to transient viral gene expression. This article provides direct evidence for the complete reversibility of the property of immortality.


Cancer Letters | 1987

Selective killing of tumor cells by xanthates

Eberhard Amtmann; Gerhard Sauer

Xanthate derivatives of primary alcohols with antiviral properties exert, in combination with monocarboxylic C11 or C12 acids a pronounced anti-tumor activity in vitro and in vivo. Tricyclodecan-9-yl-xanthogenate (D609) or cyclododecyl xanthogenate (D435) when administered together with either undecanoic or dodecanoic acid to various transformed animal and human tumor cells (displaying low serum requirement) cause cell death. In contrast, normal cells from which transformed derivatives arose, were unaffected.


Experimental Cell Research | 1988

Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound

Karin Müller-Decker; Clemens Doppler; Eberhard Amtmann; Gerhard Sauer

The binding of growth factors to the cellular receptors elicits the phosphorylation of proteins which transmit growth signals to the nucleus [E. Rozengurt (1986) Science 234, 161-166]. Both the tyrosine-specific kinase (growth factor receptor) and the threonine-serine phosphorylating protein kinase C (pkC) become activated upon binding of the epidermal growth factor (EGF) to its receptor. Here we describe the selective inhibition of the pkC activation by tricyclodecane-9-yl-xanthogenate (D609) in the presence of unsuppressed receptor tyrosine autophosphorylation. As a consequence the affinity of EGF to the receptor was not down-regulated and the complex failed to be internalized.


Journal of General Virology | 1987

Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.

Müller-Decker K; Eberhard Amtmann; Gerhard Sauer

The growth of vesicular stomatitis virus (VSV) can be inhibited by the antiviral compound tricyclo-decane-9-yl-xanthogenate (D609). On analysing the antiviral mechanism we found no effect on the primary transcription of infecting VSV genomes. In contrast, the processes of replication and transcription during late stages of infection were inhibited. Despite the synthesis of all five virus-coded proteins (41% to 56% of the uninhibited control), as shown by labelling with [35S]methionine, the phosphorylation of the non-structural (NS) protein was reduced in the presence of the xanthate by a factor of at least 17. The pattern of phosphorylation of the bulk of cellular proteins remained unaltered under the same conditions. A relation between a possible loss of biological activity of the NS protein owing to the lack of phosphorylation and the decreased VSV RNA synthesis is suggested.


FEBS Letters | 1975

Repetitive primate DNA containing the recognition sequences for two restriction endonucleases which generate cohesive ends.

Peter Gruss; Gerhard Sauer

Physical maps of the genomes of small viruses have been constructed using restriction endonucleases [1,2] and the more complex DNA of higher organisms has been studied recently. Digestion of bovine, human and murine DNA followed by electrophoretic separation of the cleavage products revealed, besides diffusely distributed unique sequences, fragments of defined length [3 -7 ] . When DNA from CV-1 cells, a permanent line derived from Cercopithecus aethiops monkey kidney cells, was treated with various restriction endonucleases, it turned out that a repetitive component of this DNA was susceptible to attack by both Eco R I and Hind III enzymes. Thus, we were able to map the distance between the respective recognition sites within a monomeric sequence. Furthermore, partial digests permitted an estimation of the size of the randomly arranged repeated DNA sequences. A more practical aspect of this work concerns the repeated DNA fragments that can be obtained after double digestion with both Eco R! and Hind Ill endonucleases. Such fragments bear cohesive ends [8-11 ] and can serve as useful linkers in molecular engineering experiments where DNA sequences of different origins bearing either the Eco R I or the Hind III termini are to be joined with each other.


Biochemical Pharmacology | 1987

Synergistic antiviral effect of xanthates and ionic detergents

Eberhard Amtmann; Karin Müller-Decker; Angela Hoss; Gunnar Schalasta; Clemens Doppler; Gerhard Sauer

Xanthate compounds have been shown to exhibit antiviral activity against various DNA and RNA viruses under acidic pH conditions. It is now possible to utilize the unique broad range antiviral spectrum of these compounds under physiological pH conditions (pH 7.4) by simultaneous administration of certain ionic detergents. When used in conjunction with tricyclodecan-9-yl-xanthate (D609), sodium deoxycholate, sodium dodecylsulfate and certain fatty acids, which have no antiviral activity of their own, inhibit the replication of various DNA and RNA viruses (such as herpes simplex, vesicular stomatitis and Coxsackie B 4) in vitro at pH 7.4. Among saturated fatty acids of various chain lengths there was a marked size restriction in that the efficiency of undecanoic acid (11 C atoms) was three orders of magnitude greater than that of shorter (6 C atoms) or longer (18 C atoms) monocarbonic acids. Dose-response kinetics revealed a synergistic interaction between the xanthate and the monocarbonic acid. A dose that inhibited the replication of herpesvirus by a factor of 1000 still permitted mitotic activity in uninfected growing control cultures.


Cancer Letters | 1990

Systemic treatment of a human epidermoid non-small cell lung carcinoma xenograft with a xanthate compound causes extensive intratumoral necrosis.

Gerhard Sauer; Eberhard Amtmann; W. Hofmann

Therapeutic effects were obtained after systemic treatment of athymic mice bearing an epidermoid non-small cell human lung carcinoma (NSCLC) xenograft with tricyclodecan-9-yl xanthogenate (D609) and the potassium salt of a fatty (dodecanoic) acid. Extensive intratumoral necrosis was observed 3 days after the treatment.


Cancer Letters | 1989

Antitumoral activity of a xanthate compound I. Cytotoxicity studies with neoplastic cell lines in vitro

Hans D. Schick; Eberhard Amtmann; Wolfgang E. Berdel; Susanne Danhauser-Riedl; A. Reichert; G. Steinhauser; J. Rastetter; Gerhard Sauer

Xanthate derivatives were shown previously to display antitumor activity against transformed fibroblasts and lymphoma cells in combination with monocarboxylic acids [1]. Various malignant cell lines of human origin were treated in vitro to explore the range of antitumoral activity of the compounds. The combination of tricyclodecan-9-yl-xanthogenate (D 609) with undecanoic acid (C11) exerted dose dependent cytotoxic and antiproliferative effects on cell lines both from solid tumors (glioblastomas, colon-carcinomas) and hematological diseases (lymphomas, CML/BC). Additionally, the combination of D 609/C11 was able to kill both methotrexate- and adriamycin-resistant L 1210 and S 180 cells, indicating that there is no cross-resistance for these drugs and D 609/C11 in vitro.

Collaboration


Dive into the Gerhard Sauer's collaboration.

Top Co-Authors

Avatar

Eberhard Amtmann

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Karin Müller-Decker

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Peter Krieg

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Clemens Doppler

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Hermann Lehn

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Sabine Volland

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Angela Hoss

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Anita C. Knapp

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Beate Hornung

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Friedrich Marks

German Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge